These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The effect of rizatriptan, ergotamine, and their combination on human peripheral arteries: a double-blind, placebo-controlled, crossover study in normal subjects. Tfelt-Hansen P; Seidelin K; Stepanavage M; Lines C Br J Clin Pharmacol; 2002 Jul; 54(1):38-44. PubMed ID: 12100223 [TBL] [Abstract][Full Text] [Related]
5. The selective closure of feline carotid arteriovenous anastomoses (AVAs) by GR43175. Perren MJ; Feniuk W; Humphrey PP Cephalalgia; 1989; 9 Suppl 9():41-6. PubMed ID: 2544282 [TBL] [Abstract][Full Text] [Related]
6. The pharmacology of the novel 5-HT1-like receptor agonist, GR43175. Humphrey PP; Feniuk W; Perren MJ; Connor HE; Oxford AW Cephalalgia; 1989; 9 Suppl 9():23-33. PubMed ID: 2544280 [TBL] [Abstract][Full Text] [Related]
7. Sumatriptan and cerebral perfusion in healthy volunteers. Scott AK; Grimes S; Ng K; Critchley M; Breckenridge AM; Thomson C; Pilgrim AJ Br J Clin Pharmacol; 1992 Apr; 33(4):401-4. PubMed ID: 1315562 [TBL] [Abstract][Full Text] [Related]
8. Sumatriptan is a potent vasoconstrictor of human dural arteries via a 5-HT1-like receptor. Jansen I; Edvinsson L; Mortensen A; Olesen J Cephalalgia; 1992 Aug; 12(4):202-5. PubMed ID: 1326402 [TBL] [Abstract][Full Text] [Related]
9. Acute effects of sumatriptan on aortic blood pressure, stiffness, and pressure waveform. Vanmolkot FH; de Hoon JN Clin Pharmacol Ther; 2006 Jul; 80(1):85-94. PubMed ID: 16815320 [TBL] [Abstract][Full Text] [Related]
10. Non-invasive assessment of selective 5-HT(1B/1D)-receptor agonist-induced peripheral vascular effects in humans: comparison of different techniques. Vanmolkot FH; de Hoon JN; Barrington P; Peck RW; Dallow NS; Williams PM; McColm J Eur J Clin Pharmacol; 2002 Aug; 58(5):303-8. PubMed ID: 12185552 [TBL] [Abstract][Full Text] [Related]
11. Mode of action of the anti-migraine drug sumatriptan. Humphrey PP; Feniuk W Trends Pharmacol Sci; 1991 Dec; 12(12):444-6. PubMed ID: 1665260 [No Abstract] [Full Text] [Related]
12. Early studies with the novel 5-HT 1-like agonist GR43175 in healthy volunteers. Fowler PA; Thomas M; Lacey LF; Andrew P; Dallas FA Cephalalgia; 1989; 9 Suppl 9():57-62. PubMed ID: 2544285 [TBL] [Abstract][Full Text] [Related]
13. Lack of antinociceptive activity of sumatriptan in rodents. Skingle M; Birch PJ; Leighton GE; Humphrey PP Cephalalgia; 1990 Oct; 10(5):207-12. PubMed ID: 2176936 [TBL] [Abstract][Full Text] [Related]
14. Vascular effects of the new anti-migraine agent almotriptan on human cranial and peripheral arteries. Bou J; Gras J; Cortijo J; Morcillo EJ; Llenas J; Palacios JM Cephalalgia; 2001 Oct; 21(8):804-12. PubMed ID: 11737005 [TBL] [Abstract][Full Text] [Related]
15. Lack of an interaction between propranolol and sumatriptan. Scott AK; Walley T; Breckenridge AM; Lacey LF; Fowler PA Br J Clin Pharmacol; 1991 Nov; 32(5):581-4. PubMed ID: 1659437 [TBL] [Abstract][Full Text] [Related]
16. A double-blind, randomized, crossover assessment of blood pressure following administration of avitriptan, sumatriptan, or placebo to patients with mild to moderate hypertension. Jhee SS; Salazar DE; Ford NF; Fulmor IE; Sramek JJ; Cutler NR Cephalalgia; 1999 Mar; 19(2):95-9. PubMed ID: 10214534 [TBL] [Abstract][Full Text] [Related]
17. Lack of effect of flunarizine on the pharmacokinetics and pharmacodynamics of sumatriptan in healthy volunteers. Van Hecken AM; Depré M; De Schepper PJ; Fowler PA; Lacey LF; Durham JM Br J Clin Pharmacol; 1992 Jul; 34(1):82-4. PubMed ID: 1321655 [TBL] [Abstract][Full Text] [Related]